No Apparent Benefit at 5 Years From a Course of Neoadjuvant/Concurrent Androgen Deprivation for Patients With Prostate Cancer Treated With a High Total Radiation Dose-Reference-Cited by-同舟云学术

No Apparent Benefit at 5 Years From a Course of Neoadjuvant/Concurrent Androgen Deprivation for Patients With Prostate Cancer Treated With a High Total Radiation Dose

Published:2003-12 Issue:6 Volume:170 Page:2296-2301
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

MARTINEZ ALVARO¹,GALALAE RAZVAN¹,GONZALEZ JOSE¹,MITCHELL CHRISTINA¹,GUSTAFSON GARY¹,KOVACS GYORGY¹

Affiliation:

1. From the Departments of Radiation Oncology (AM, CM, GG) and Urology (JG), William Beaumont Hospital, Royal Oak, Michigan, and Department of Radiation Oncology, Kiel University Hospital (RG, GK), Kiel, Germany

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference21 articles.

1. Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy;Horwitz;Int J Radiat Oncol Biol Phys,2001

2. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer;Laverdiere;Int J Radiat Oncol Biol Phys,1997

3. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997

4. Predicting survival and the role of androgen suppressive therapy (AST): Radiation Therapy Oncology Group (RTOG) phase III randomized prostate cancer trials;Roach;Int J Radiat Oncol Biol Phys,1998

5. RTOG 92-02: a phase III trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate;Hanks;Int J Radiat Oncol Biol Phys,2000

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. American Brachytherapy Society Task Group Report: Use of androgen deprivation therapy with prostate brachytherapy—A systematic literature review;Brachytherapy;2017-03

2. Significant association of brachytherapy boost with reduced prostate cancer–specific mortality in contemporary patients with localized, unfavorable-risk prostate cancer;Brachytherapy;2015-11

3. Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era;Critical Reviews in Oncology/Hematology;2015-02

4. High-Dose-Rate Brachytherapy in the Treatment of Clinically Localized Prostate Cancer;Radiotherapy in Prostate Cancer;2014

5. The relative importance of hormonal therapy and biological effective dose in optimizing prostate brachytherapy treatment outcomes;BJU International;2013-06-14